Global Circulating Tumor Cells (CTC) Professional Survey Report 2023, Forecast to 2028
are cells that have detached from a primary tumor and circulate in the bloodstream.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period.
Data collected includes market dynamics, technology outlook, application development, and pricing trends. All of this is fed into a research model, which then produces relevant data for market research. Global market trend analysis is given including historical data, estimates to 2023 and compound annual growth rate (CAGR) forecast to 2028.
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
2023 will be a tough year for much of the global economy, as the ongoing war in Ukraine continues to strain trade, especially in Europe, and the global economy remains reeling from the fallout from the COVID-19 pandemic.
But as China moves ever closer to fully reemerging from three years of government-imposed Covid isolation and reintegrating with the world, economic expectations are high.And with the global economy now facing significant challenges, including energy shortages, slowing growth and high inflation, China’s reopening could provide a much-needed and timely boost.
The report researches and analyzes the influence of the Circulating Tumor Cells (CTC) industry in the new era of global post-COIVD-19 economy in 2023, and provides in-depth analysis and professional suggestions on the current development.
Market Segment by Product Type
CTC Enrichment
CTC Detection
CTC Analysis
Market Segment by Product Application
Breast Cancer
Prostate Cancer
Colorectal Cancer
Lung Cancer
Other
Finally, the report provides detailed profile and data information analysis of leading company.
Menarini-Silicon Biosystems
SurExamBio-Tech
ApoCell
Qiagen (Adnagen)
Cynvenio
Advanced Cell Diagnostics
Ikonisys
Greiner Bio-one GmbH
Epic Sciences
Fluxion Biosciences
Celsee
Hangzhou Watson Biotech
Clearbridge Biomedics
Guangzhou Wondfo Biotech
Biocept
ANGLE plc
CytoTrack
Insights and Tools:
We follow a comprehensive process to estimate market size. Key industry dynamics, regulatory scenarios, and segmental dynamics are analyzed to understand their impact on demand over the forecast period. Macroeconomic indicators such as prices, income and demographic changes, demand changes, etc. are considered in estimating market size. We also provide an in-depth profile of the key players and discuss their market shares in the global market to derive the market value. In addition, we have an internal database that is regularly updated with key insights and press releases from key stakeholders in the relevant market.
The data is generally gathered in various arrangements such as charts, graphs, infographics, trends, documents and records from various manufacturers and retailers. Our analyst gather, collect, and interpret such data to form significant databases. Our team then works with large data volumes to analyze core developments, evaluate market estimations, and identify trends.
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
Research Objectives
1.To study and analyze the global Circulating Tumor Cells (CTC) consumption (value) by key regions/countries, product type and application, history data from 2018 to 2022, and forecast to 2028.
2.To understand the structure of Circulating Tumor Cells (CTC) market by identifying its various subsegments.
3.Focuses on the key global Circulating Tumor Cells (CTC) manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Circulating Tumor Cells (CTC) with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Circulating Tumor Cells (CTC) submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Global Circulating Tumor Cells (CTC) Professional Survey Report Report 2023, Forecast to 2028
1 Market Study Overview
1.1 Study Objectives
1.2 Circulating Tumor Cells (CTC) Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research Methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Circulating Tumor Cells (CTC) Segment by Type
2.1.1 CTC Enrichment
2.1.2 CTC Detection
2.1.3 CTC Analysis
2.2 Market Analysis by Application
2.2.1 Breast Cancer
2.2.2 Prostate Cancer
2.2.3 Colorectal Cancer
2.2.4 Lung Cancer
2.2.5 Other
2.3 Global Circulating Tumor Cells (CTC) Market Comparison by Regions (2018-2028)
2.3.1 Global Circulating Tumor Cells (CTC) Market Size (2018-2028)
2.3.2 North America Circulating Tumor Cells (CTC) Status and Prospect (2018-2028)
2.3.3 Europe Circulating Tumor Cells (CTC) Status and Prospect (2018-2028)
2.3.4 Asia-pacific Circulating Tumor Cells (CTC) Status and Prospect (2018-2028)
2.3.5 South America Circulating Tumor Cells (CTC) Status and Prospect (2018-2028)
2.3.6 Middle East & Africa Circulating Tumor Cells (CTC) Status and Prospect (2018-2028)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2020 (Covid-19): Circulating Tumor Cells (CTC) Industry Impact
2.5.1 Circulating Tumor Cells (CTC) Business Impact Assessment - Covid-19
2.5.2 Market Trends and Circulating Tumor Cells (CTC) Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Circulating Tumor Cells (CTC) Sales and Market Share by Manufacturer (2018-2023)
3.2 Global Circulating Tumor Cells (CTC) Revenue and Market Share by Manufacturer (2018-2023)
3.3 Global Circulating Tumor Cells (CTC) Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Circulating Tumor Cells (CTC) Manufacturer Market Share
3.5 Top 10 Circulating Tumor Cells (CTC) Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Circulating Tumor Cells (CTC) Market
3.7 Key Manufacturers Circulating Tumor Cells (CTC) Product Offered
3.8 Mergers & Acquisitions Planning
4 Analysis of Circulating Tumor Cells (CTC) Industry Key Manufacturers
4.1 Menarini-Silicon Biosystems
4.1.1 Company Details
4.1.2 Menarini-Silicon Biosystems Circulating Tumor Cells (CTC) Product Introduction, Application and Specification
4.1.3 Menarini-Silicon Biosystems Circulating Tumor Cells (CTC) Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.1.4 Main Business Overview
4.1.5 Menarini-Silicon Biosystems News
4.2 SurExamBio-Tech
4.2.1 Company Details
4.2.2 SurExamBio-Tech Circulating Tumor Cells (CTC) Product Introduction, Application and Specification
4.2.3 SurExamBio-Tech Circulating Tumor Cells (CTC) Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.2.4 Main Business Overview
4.2.5 SurExamBio-Tech News
4.3 ApoCell
4.3.1 Company Details
4.3.2 ApoCell Circulating Tumor Cells (CTC) Product Introduction, Application and Specification
4.3.3 ApoCell Circulating Tumor Cells (CTC) Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.3.4 Main Business Overview
4.3.5 ApoCell News
4.4 Qiagen (Adnagen)
4.4.1 Company Details
4.4.2 Qiagen (Adnagen) Circulating Tumor Cells (CTC) Product Introduction, Application and Specification
4.4.3 Qiagen (Adnagen) Circulating Tumor Cells (CTC) Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.4.4 Main Business Overview
4.4.5 Qiagen (Adnagen) News
4.5 Cynvenio
4.5.1 Company Details
4.5.2 Cynvenio Circulating Tumor Cells (CTC) Product Introduction, Application and Specification
4.5.3 Cynvenio Circulating Tumor Cells (CTC) Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.5.4 Main Business Overview
4.5.5 Cynvenio News
4.6 Advanced Cell Diagnostics
4.6.1 Company Details
4.6.2 Advanced Cell Diagnostics Circulating Tumor Cells (CTC) Product Introduction, Application and Specification
4.6.3 Advanced Cell Diagnostics Circulating Tumor Cells (CTC) Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.6.4 Main Business Overview
4.6.5 Advanced Cell Diagnostics News
4.7 Ikonisys
4.7.1 Company Details
4.7.2 Ikonisys Circulating Tumor Cells (CTC) Product Introduction, Application and Specification
4.7.3 Ikonisys Circulating Tumor Cells (CTC) Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.7.4 Main Business Overview
4.7.5 Ikonisys News
4.8 Greiner Bio-one GmbH
4.8.1 Company Details
4.8.2 Greiner Bio-one GmbH Circulating Tumor Cells (CTC) Product Introduction, Application and Specification
4.8.3 Greiner Bio-one GmbH Circulating Tumor Cells (CTC) Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.8.4 Main Business Overview
4.8.5 Greiner Bio-one GmbH News
4.9 Epic Sciences
4.9.1 Company Details
4.9.2 Epic Sciences Circulating Tumor Cells (CTC) Product Introduction, Application and Specification
4.9.3 Epic Sciences Circulating Tumor Cells (CTC) Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.9.4 Main Business Overview
4.9.5 Epic Sciences News
4.10 Fluxion Biosciences
4.10.1 Company Details
4.10.2 Fluxion Biosciences Circulating Tumor Cells (CTC) Product Introduction, Application and Specification
4.10.3 Fluxion Biosciences Circulating Tumor Cells (CTC) Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.10.4 Main Business Overview
4.10.5 Fluxion Biosciences News
4.11 Celsee
4.11.1 Company Details
4.11.2 Celsee Circulating Tumor Cells (CTC) Product Introduction, Application and Specification
4.11.3 Celsee Circulating Tumor Cells (CTC) Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.11.4 Main Business Overview
4.11.5 Celsee News
4.12 Hangzhou Watson Biotech
4.12.1 Company Details
4.12.2 Hangzhou Watson Biotech Circulating Tumor Cells (CTC) Product Introduction, Application and Specification
4.12.3 Hangzhou Watson Biotech Circulating Tumor Cells (CTC) Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.12.4 Main Business Overview
4.12.5 Hangzhou Watson Biotech News
4.13 Clearbridge Biomedics
4.13.1 Company Details
4.13.2 Clearbridge Biomedics Circulating Tumor Cells (CTC) Product Introduction, Application and Specification
4.13.3 Clearbridge Biomedics Circulating Tumor Cells (CTC) Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.13.4 Main Business Overview
4.13.5 Clearbridge Biomedics News
4.14 Guangzhou Wondfo Biotech
4.14.1 Company Details
4.14.2 Guangzhou Wondfo Biotech Circulating Tumor Cells (CTC) Product Introduction, Application and Specification
4.14.3 Guangzhou Wondfo Biotech Circulating Tumor Cells (CTC) Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.14.4 Main Business Overview
4.14.5 Guangzhou Wondfo Biotech News
4.15 Biocept
4.15.1 Company Details
4.15.2 Biocept Circulating Tumor Cells (CTC) Product Introduction, Application and Specification
4.15.3 Biocept Circulating Tumor Cells (CTC) Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.15.4 Main Business Overview
4.15.5 Biocept News
4.16 ANGLE plc
4.16.1 Company Details
4.16.2 ANGLE plc Circulating Tumor Cells (CTC) Product Introduction, Application and Specification
4.16.3 ANGLE plc Circulating Tumor Cells (CTC) Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.16.4 Main Business Overview
4.16.5 ANGLE plc News
4.17 CytoTrack
4.17.1 Company Details
4.17.2 CytoTrack Circulating Tumor Cells (CTC) Product Introduction, Application and Specification
4.17.3 CytoTrack Circulating Tumor Cells (CTC) Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.17.4 Main Business Overview
4.17.5 CytoTrack News
5 Global Circulating Tumor Cells (CTC) Sales Categorized by Regions
5.1 Global Circulating Tumor Cells (CTC) Revenue, Sales and Market Share by Regions
5.1.1 Global Circulating Tumor Cells (CTC) Sales and Market Share by Regions (2018-2023)
5.1.2 Global Circulating Tumor Cells (CTC) Revenue and Market Share by Regions (2018-2023)
5.2 North America Circulating Tumor Cells (CTC) Sales and Growth Rate (2018-2023)
5.3 Europe Circulating Tumor Cells (CTC) Sales and Growth Rate (2018-2023)
5.4 Asia-pacific Circulating Tumor Cells (CTC) Sales and Growth Rate (2018-2023)
5.5 South America Circulating Tumor Cells (CTC) Sales and Growth Rate (2018-2023)
5.6 Middle East & Africa Circulating Tumor Cells (CTC) Sales and Growth Rate (2018-2023)
6 North America Circulating Tumor Cells (CTC) Market Size Categorized by Countries
6.1 North America Circulating Tumor Cells (CTC) Sales, Revenue and Market Share by Countries
6.1.1 North America Circulating Tumor Cells (CTC) Sales (Volume) by Countries (2018-2023)
6.1.2 North America Circulating Tumor Cells (CTC) Revenue by Countries (2018-2023)
6.1.3 United States Circulating Tumor Cells (CTC) Sales and Growth Rate (2018-2023)
6.1.4 Canada Circulating Tumor Cells (CTC) Sales and Growth Rate (2018-2023)
6.1.5 Mexico Circulating Tumor Cells (CTC) Sales and Growth Rate (2018-2023)
6.2 North America Circulating Tumor Cells (CTC) Revenue (Value) by Manufacturers
6.3 North America Circulating Tumor Cells (CTC) Sales and Market Share by Type (2018-2023)
6.4 North America Circulating Tumor Cells (CTC) Sales Market Share by Application (2018-2023)
7 Europe Circulating Tumor Cells (CTC) Market Size Categorized by Countries
7.1 Europe Circulating Tumor Cells (CTC) Sales, Revenue and Market Share by Countries
7.1.1 Europe Circulating Tumor Cells (CTC) Sales (Volume) by Countries (2018-2023)
7.1.2 Europe Circulating Tumor Cells (CTC) Revenue by Countries (2018-2023)
7.1.3 Germany Circulating Tumor Cells (CTC) Sales and Growth Rate (2018-2023)
7.1.4 UK Circulating Tumor Cells (CTC) Sales and Growth Rate (2018-2023)
7.1.5 France Circulating Tumor Cells (CTC) Sales and Growth Rate (2018-2023)
7.1.6 Russia Circulating Tumor Cells (CTC) Sales and Growth Rate (2018-2023)
7.1.7 Italy Circulating Tumor Cells (CTC) Sales and Growth Rate (2018-2023)
7.1.8 Spain Circulating Tumor Cells (CTC) Sales and Growth Rate (2018-2023)
7.2 Europe Circulating Tumor Cells (CTC) Revenue (Value) by Manufacturers
7.3 Europe Circulating Tumor Cells (CTC) Sales and Market Share by Type (2018-2023)
7.4 Europe Circulating Tumor Cells (CTC) Sales Market Share by Application (2018-2023)
8 Asia-Pacific Circulating Tumor Cells (CTC) Market Size Categorized by Countries
8.1 Asia-pacific Circulating Tumor Cells (CTC) Sales, Revenue and Market Share by Countries
8.1.1 Asia-pacific Circulating Tumor Cells (CTC) Sales (Volume) by Countries (2018-2023)
8.1.2 Asia-pacific Circulating Tumor Cells (CTC) Revenue by Countries (2018-2023)
8.1.3 China Circulating Tumor Cells (CTC) Sales and Growth Rate (2018-2023)
8.1.4 South Korea Circulating Tumor Cells (CTC) Sales and Growth Rate (2018-2023)
8.1.5 Japan Circulating Tumor Cells (CTC) Sales and Growth Rate (2018-2023)
8.1.6 Australia Circulating Tumor Cells (CTC) Sales and Growth Rate (2018-2023)
8.1.7 India Circulating Tumor Cells (CTC) Sales and Growth Rate (2018-2023)
8.1.8 Southeast Asia Circulating Tumor Cells (CTC) Sales and Growth Rate (2018-2023)
8.2 Asia-pacific Circulating Tumor Cells (CTC) Revenue (Value) by Manufacturers
8.3 Asia-pacific Circulating Tumor Cells (CTC) Sales and Market Share by Type (2018-2023)
8.4 Asia-pacific Circulating Tumor Cells (CTC) Sales Market Share by Application (2018-2023)
9 South America Circulating Tumor Cells (CTC) Market Size Categorized by Countries
9.1 South America Circulating Tumor Cells (CTC) Sales, Revenue and Market Share by Countries
9.1.1 South America Circulating Tumor Cells (CTC) Sales (Volume) by Countries (2018-2023)
9.1.2 South America Circulating Tumor Cells (CTC) Revenue by Countries (2018-2023)
9.1.3 Brazil Circulating Tumor Cells (CTC) Sales and Growth Rate (2018-2023)
9.2 South America Circulating Tumor Cells (CTC) Sales and Market Share by Type (2018-2023)
9.3 South America Circulating Tumor Cells (CTC) Sales Market Share by Application (2018-2023)
10 Middle East and Africa Circulating Tumor Cells (CTC) Market Size Categorized by Countries
10.1 Middle East and Africa Circulating Tumor Cells (CTC) Sales, Revenue and Market Share by Countries
10.1.1 Middle East and Africa Circulating Tumor Cells (CTC) Sales (Volume) by Countries (2018-2023)
10.1.2 Middle East and Africa Circulating Tumor Cells (CTC) Revenue by Countries (2018-2023)
10.1.3 GCC Countries Circulating Tumor Cells (CTC) Sales and Growth Rate (2018-2023)
10.1.4 Turkey Circulating Tumor Cells (CTC) Sales and Growth Rate (2018-2023)
10.1.5 Egypt Circulating Tumor Cells (CTC) Sales and Growth Rate (2018-2023)
10.1.6 South America Circulating Tumor Cells (CTC) Sales and Growth Rate (2018-2023)
10.2 Middle East and Africa Circulating Tumor Cells (CTC) Sales and Market Share by Type
10.3 Middle East and Africa Circulating Tumor Cells (CTC) Sales Market Share by Application (2018-2023)
11 Global Circulating Tumor Cells (CTC) Market Segment by Type
11.1 Global Circulating Tumor Cells (CTC) Revenue, Sales and Market Share by Type (2018-2023)
11.1.1 Global Circulating Tumor Cells (CTC) Sales and Market Share by Type (2018-2023)
11.1.2 Global Circulating Tumor Cells (CTC) Revenue and Market Share by Type (2018-2023)
11.2 CTC Enrichment Sales Growth Rate and Price
11.2.1 Global CTC Enrichment Sales Growth Rate (2018-2023)
11.2.2 Global CTC Enrichment Price (2018-2023)
11.3 CTC Detection Sales Growth Rate and Price
11.3.1 Global CTC Detection Sales Growth Rate (2018-2023)
11.3.2 Global CTC Detection Price (2018-2023)
11.4 CTC Analysis Sales Growth Rate and Price
11.4.1 Global CTC Analysis Sales Growth Rate (2018-2023)
11.4.2 Global CTC Analysis Price (2018-2023)
12 Global Circulating Tumor Cells (CTC) Market Segment by Application
12.1 Global Circulating Tumor Cells (CTC) Sales Market Share by Application (2018-2023)
12.2 Breast Cancer Sales Growth Rate (2018-2023)
12.3 Prostate Cancer Sales Growth Rate (2018-2023)
12.4 Colorectal Cancer Sales Growth Rate (2018-2023)
12.5 Lung Cancer Sales Growth Rate (2018-2023)
13 Global Circulating Tumor Cells (CTC) Market Forecast
13.1 Global Circulating Tumor Cells (CTC) Revenue, Sales and Growth Rate (2023-2028)
13.2 Circulating Tumor Cells (CTC) Market Forecast by Regions (2023-2028)
13.2.1 North America Circulating Tumor Cells (CTC) Market Forecast (2023-2028)
13.2.2 Europe Circulating Tumor Cells (CTC) Market Forecast (2023-2028)
13.2.3 Asia-Pacific Circulating Tumor Cells (CTC) Market Forecast (2023-2028)
13.2.4 South America Circulating Tumor Cells (CTC) Market Forecast (2023-2028)
13.2.5 Middle East & Africa Circulating Tumor Cells (CTC) Market Forecast (2023-2028)
13.3 Circulating Tumor Cells (CTC) Market Forecast by Type (2023-2028)
13.3.1 Global Circulating Tumor Cells (CTC) Sales Forecast by Type (2023-2028)
13.3.2 Global Circulating Tumor Cells (CTC) Market Share Forecast by Type (2023-2028)
13.4 Circulating Tumor Cells (CTC) Market Forecast by Application (2023-2028)
13.4.1 Global Circulating Tumor Cells (CTC) Sales Forecast by Application (2023-2028)
13.4.2 Global Circulating Tumor Cells (CTC) Market Share Forecast by Application (2023-2028)
14 Market Analysis
14.1.1 Market overview
14.1.2 Market Opportunities
14.1.3 Market Risk
14.1.4 Market Driving Force
14.1.5 Porter's Five Forces Analysis
14.1.6 SWOT Analysis
15 Circulating Tumor Cells (CTC) Industry Related Market Analysis
15.1 Upstream Analysis
15.1.1 Macro Analysis of Upstream Markets
15.1.2 Key Players in Upstream Markets
15.1.3 Upstream Market Trend Analysis
15.1.4 Circulating Tumor Cells (CTC) Manufacturing Cost Analysis
15.2 Downstream Market Analysis
15.2.1 Macro Analysis of Down Markets
15.2.2 Key Players in Down Markets
15.2.3 Downstream Market Trend Analysis
15.2.4 Sales Channel, Distributors, Traders and Dealers
List of Tables and Figures
Figure Product Picture Circulating Tumor Cells (CTC)
Figure Market Concentration Ratio and Market Maturity Analysis of Circulating Tumor Cells (CTC)
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Circulating Tumor Cells (CTC) Market Size by Type
Figure Global Market Share of Circulating Tumor Cells (CTC) by Type in 2022
Figure CTC Enrichment Picture
Figure CTC Detection Picture
Figure CTC Analysis Picture
Table Global Circulating Tumor Cells (CTC) Market Size (Volume) by Application
Figure Breast Cancer Picture
Figure Prostate Cancer Picture
Figure Colorectal Cancer Picture
Figure Lung Cancer Picture
Figure Other Picture
Table Global Circulating Tumor Cells (CTC) Comparison by Regions (M USD) 2018-2028
Figure Global Circulating Tumor Cells (CTC) Market Size (Million US$) (2018-2028)
Figure North America Circulating Tumor Cells (CTC) Revenue (Million US$) Growth Rate (2018-2028)
Figure Europe Circulating Tumor Cells (CTC) Revenue (Million US$) Growth Rate (2018-2028)
Figure Asia-pacific Circulating Tumor Cells (CTC) Revenue (Million US$) Growth Rate (2018-2028)
Figure South America Circulating Tumor Cells (CTC) Revenue (Million US$) Growth Rate (2018-2028)
Figure Middle East & Africa Circulating Tumor Cells (CTC) Revenue (Million US$) Growth Rate (2018-2028)
Table Business Impact Assessment - Covid-19
Table Market Trends and Circulating Tumor Cells (CTC) Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Circulating Tumor Cells (CTC) Sales by Manufacturer (2018-2023)
Figure Global Circulating Tumor Cells (CTC) Sales Market Share by Manufacturer in 2022
Table Global Circulating Tumor Cells (CTC) Revenue by Manufacturer (2018-2023)
Figure Global Circulating Tumor Cells (CTC) Revenue Market Share by Manufacturer in 2022
Table Global Circulating Tumor Cells (CTC) Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Circulating Tumor Cells (CTC) Manufacturer (Revenue) Market Share in 2022
Figure Top 10 Circulating Tumor Cells (CTC) Manufacturer (Revenue) Market Share in 2022
Table Date of Key Manufacturers Enter into Circulating Tumor Cells (CTC) Market
Table Key Manufacturers Circulating Tumor Cells (CTC) Product Type
Table Mergers & Acquisitions Planning
Table Menarini-Silicon Biosystems Company Profile
Table Circulating Tumor Cells (CTC) Product Introduction, Application and Specification of Menarini-Silicon Biosystems
Table Circulating Tumor Cells (CTC) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Menarini-Silicon Biosystems 2018-2023
Table Menarini-Silicon Biosystems Main Business
Table Menarini-Silicon Biosystems Recent Development
Table SurExamBio-Tech Company Profile
Table Circulating Tumor Cells (CTC) Product Introduction, Application and Specification of SurExamBio-Tech
Table Circulating Tumor Cells (CTC) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of SurExamBio-Tech 2018-2023
Table SurExamBio-Tech Main Business
Table SurExamBio-Tech Recent Development
Table ApoCell Company Profile
Table Circulating Tumor Cells (CTC) Product Introduction, Application and Specification of ApoCell
Table Circulating Tumor Cells (CTC) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of ApoCell 2018-2023
Table ApoCell Main Business
Table ApoCell Recent Development
Table Qiagen (Adnagen) Company Profile
Table Circulating Tumor Cells (CTC) Product Introduction, Application and Specification of Qiagen (Adnagen)
Table Circulating Tumor Cells (CTC) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Qiagen (Adnagen) 2018-2023
Table Qiagen (Adnagen) Main Business
Table Qiagen (Adnagen) Recent Development
Table Cynvenio Company Profile
Table Circulating Tumor Cells (CTC) Product Introduction, Application and Specification of Cynvenio
Table Circulating Tumor Cells (CTC) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Cynvenio 2018-2023
Table Cynvenio Main Business
Table Cynvenio Recent Development
Table Advanced Cell Diagnostics Company Profile
Table Circulating Tumor Cells (CTC) Product Introduction, Application and Specification of Advanced Cell Diagnostics
Table Circulating Tumor Cells (CTC) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Advanced Cell Diagnostics 2018-2023
Table Advanced Cell Diagnostics Main Business
Table Advanced Cell Diagnostics Recent Development
Table Ikonisys Company Profile
Table Circulating Tumor Cells (CTC) Product Introduction, Application and Specification of Ikonisys
Table Circulating Tumor Cells (CTC) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Ikonisys 2018-2023
Table Ikonisys Main Business
Table Ikonisys Recent Development
Table Greiner Bio-one GmbH Company Profile
Table Circulating Tumor Cells (CTC) Product Introduction, Application and Specification of Greiner Bio-one GmbH
Table Circulating Tumor Cells (CTC) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Greiner Bio-one GmbH 2018-2023
Table Greiner Bio-one GmbH Main Business
Table Greiner Bio-one GmbH Recent Development
Table Epic Sciences Company Profile
Table Circulating Tumor Cells (CTC) Product Introduction, Application and Specification of Epic Sciences
Table Circulating Tumor Cells (CTC) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Epic Sciences 2018-2023
Table Epic Sciences Main Business
Table Epic Sciences Recent Development
Table Fluxion Biosciences Company Profile
Table Circulating Tumor Cells (CTC) Product Introduction, Application and Specification of Fluxion Biosciences
Table Circulating Tumor Cells (CTC) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Fluxion Biosciences 2018-2023
Table Fluxion Biosciences Main Business
Table Fluxion Biosciences Recent Development
Table Celsee Company Profile
Table Circulating Tumor Cells (CTC) Product Introduction, Application and Specification of Celsee
Table Circulating Tumor Cells (CTC) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Celsee 2018-2023
Table Celsee Main Business
Table Celsee Recent Development
Table Hangzhou Watson Biotech Company Profile
Table Circulating Tumor Cells (CTC) Product Introduction, Application and Specification of Hangzhou Watson Biotech
Table Circulating Tumor Cells (CTC) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Hangzhou Watson Biotech 2018-2023
Table Hangzhou Watson Biotech Main Business
Table Hangzhou Watson Biotech Recent Development
Table Clearbridge Biomedics Company Profile
Table Circulating Tumor Cells (CTC) Product Introduction, Application and Specification of Clearbridge Biomedics
Table Circulating Tumor Cells (CTC) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Clearbridge Biomedics 2018-2023
Table Clearbridge Biomedics Main Business
Table Clearbridge Biomedics Recent Development
Table Guangzhou Wondfo Biotech Company Profile
Table Circulating Tumor Cells (CTC) Product Introduction, Application and Specification of Guangzhou Wondfo Biotech
Table Circulating Tumor Cells (CTC) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Guangzhou Wondfo Biotech 2018-2023
Table Guangzhou Wondfo Biotech Main Business
Table Guangzhou Wondfo Biotech Recent Development
Table Biocept Company Profile
Table Circulating Tumor Cells (CTC) Product Introduction, Application and Specification of Biocept
Table Circulating Tumor Cells (CTC) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Biocept 2018-2023
Table Biocept Main Business
Table Biocept Recent Development
Table ANGLE plc Company Profile
Table Circulating Tumor Cells (CTC) Product Introduction, Application and Specification of ANGLE plc
Table Circulating Tumor Cells (CTC) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of ANGLE plc 2018-2023
Table ANGLE plc Main Business
Table ANGLE plc Recent Development
Table CytoTrack Company Profile
Table Circulating Tumor Cells (CTC) Product Introduction, Application and Specification of CytoTrack
Table Circulating Tumor Cells (CTC) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of CytoTrack 2018-2023
Table CytoTrack Main Business
Table CytoTrack Recent Development
Figure Global Circulating Tumor Cells (CTC) Sales and Growth Rate (2018-2023)
Figure Global Circulating Tumor Cells (CTC) Revenue and Growth Rate (2018-2023)
Table Global Circulating Tumor Cells (CTC) Sales by Regions (2018-2023)
Figure Global Circulating Tumor Cells (CTC) Sales Market Share by Regions in 2022
Table Global Circulating Tumor Cells (CTC) Revenue by Regions (2018-2023)
Figure Global Circulating Tumor Cells (CTC) Revenue Market Share by Regions in 2022
Figure North America Circulating Tumor Cells (CTC) Sales and Growth Rate (2018-2023)
Figure Europe Circulating Tumor Cells (CTC) Sales and Growth Rate (2018-2023)
Figure Asia-pacific Circulating Tumor Cells (CTC) Sales and Growth Rate (2018-2023)
Figure South America Circulating Tumor Cells (CTC) Sales and Growth Rate (2018-2023)
Figure Middle East & Africa Circulating Tumor Cells (CTC) Sales and Growth Rate (2018-2023)
Figure North America Circulating Tumor Cells (CTC) Revenue and Growth Rate (2018-2023)
Table North America Circulating Tumor Cells (CTC) Sales (Volume) by Countries (2018-2023)
Table North America Circulating Tumor Cells (CTC) Sales Market Share by Countries (2018-2023)
Figure North America Circulating Tumor Cells (CTC) Sales Market Share by Countries in 2022
Table North America Circulating Tumor Cells (CTC) Revenue by Countries (2018-2023)
Table North America Circulating Tumor Cells (CTC) Revenue Market Share by Countries (2018-2023)
Figure North America Circulating Tumor Cells (CTC) Revenue Market Share by Countries in 2022
Figure United States Circulating Tumor Cells (CTC) Sales and Growth Rate (2018-2023)
Figure Canada Circulating Tumor Cells (CTC) Sales and Growth Rate (2018-2023)
Figure Mexico Circulating Tumor Cells (CTC) Sales and Growth Rate (2018-2023)
Table North America Circulating Tumor Cells (CTC) Revenue by Manufacturer (2022)
Figure North America Circulating Tumor Cells (CTC) Revenue Market Share by Manufacturer in 2022
Table North America Circulating Tumor Cells (CTC) Sales by Type (2018-2023)
Table North America Circulating Tumor Cells (CTC) Sales Share by Type (2018-2023)
Table North America Circulating Tumor Cells (CTC) Sales by Application (2018-2023)
Table North America Circulating Tumor Cells (CTC) Sales Share by Application (2018-2023)
Figure Europe Circulating Tumor Cells (CTC) Revenue and Growth Rate (2018-2023)
Table Europe Circulating Tumor Cells (CTC) Sales (Volume) by Countries (2018-2023)
Table Europe Circulating Tumor Cells (CTC) Sales Market Share by Countries (2018-2023)
Figure Europe Circulating Tumor Cells (CTC) Sales Market Share by Countries in 2022
Table Europe Circulating Tumor Cells (CTC) Revenue by Countries (2018-2023)
Table Europe Circulating Tumor Cells (CTC) Revenue Market Share by Countries (2018-2023)
Figure Europe Circulating Tumor Cells (CTC) Revenue Market Share by Countries in 2022
Figure Germany Circulating Tumor Cells (CTC) Sales and Growth Rate (2018-2023)
Figure UK Circulating Tumor Cells (CTC) Sales and Growth Rate (2018-2023)
Figure France Circulating Tumor Cells (CTC) Sales and Growth Rate (2018-2023)
Figure Russia Circulating Tumor Cells (CTC) Sales and Growth Rate (2018-2023)
Figure Italy Circulating Tumor Cells (CTC) Sales and Growth Rate (2018-2023)
Figure Spain Circulating Tumor Cells (CTC) Sales and Growth Rate (2018-2023)
Table Europe Circulating Tumor Cells (CTC) Revenue by Manufacturer (2022)
Figure Europe Circulating Tumor Cells (CTC) Revenue Market Share by Manufacturer in 2022
Table Europe Circulating Tumor Cells (CTC) Sales by Type (2018-2023)
Table Europe Circulating Tumor Cells (CTC) Sales Share by Type (2018-2023)
Table Europe Circulating Tumor Cells (CTC) Sales by Application (2018-2023)
Table Europe Circulating Tumor Cells (CTC) Sales Share by Application (2018-2023)
Figure Asia-pacific Circulating Tumor Cells (CTC) Revenue and Growth Rate (2018-2023)
Table Asia-pacific Circulating Tumor Cells (CTC) Sales (Volume) by Countries (2018-2023)
Table Asia-pacific Circulating Tumor Cells (CTC) Sales Market Share by Countries (2018-2023)
Figure Asia-pacific Circulating Tumor Cells (CTC) Sales Market Share by Countries in 2022
Table Asia-pacific Circulating Tumor Cells (CTC) Revenue by Countries (2018-2023)
Table Asia-pacific Circulating Tumor Cells (CTC) Revenue Market Share by Countries (2018-2023)
Figure Asia-pacific Circulating Tumor Cells (CTC) Revenue Market Share by Countries in 2022
Figure China Circulating Tumor Cells (CTC) Sales and Growth Rate (2018-2023)
Figure South Korea Circulating Tumor Cells (CTC) Sales and Growth Rate (2018-2023)
Figure Japan Circulating Tumor Cells (CTC) Sales and Growth Rate (2018-2023)
Figure Australia Circulating Tumor Cells (CTC) Sales and Growth Rate (2018-2023)
Figure India Circulating Tumor Cells (CTC) Sales and Growth Rate (2018-2023)
Figure Southeast Asia Circulating Tumor Cells (CTC) Sales and Growth Rate (2018-2023)
Table Asia-pacific Circulating Tumor Cells (CTC) Revenue by Manufacturer (2022)
Figure Asia-pacific Circulating Tumor Cells (CTC) Revenue Market Share by Manufacturer in 2022
Table Asia-pacific Circulating Tumor Cells (CTC) Sales by Type (2018-2023)
Table Asia-pacific Circulating Tumor Cells (CTC) Sales Share by Type (2018-2023)
Table Asia-pacific Circulating Tumor Cells (CTC) Sales by Application (2018-2023)
Table Asia-pacific Circulating Tumor Cells (CTC) Sales Share by Application (2018-2023)
Figure South America Circulating Tumor Cells (CTC) Revenue and Growth Rate (2018-2023)
Table South America Circulating Tumor Cells (CTC) Sales (Volume) by Countries (2018-2023)
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|